pazopanib
- Product NDC
- 82293-022
- 11-digit product format
- 822930022
- Labeler code
- 82293
- Product ID
- 82293-022_2007980f-ffca-6d8f-e063-6294a90ae3ff
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- pazopanib hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Novugen Pharma (USA) LLC.
- Application
- ANDA218231
- Marketing category
- ANDA
- Marketing start
- 2024-04-24
- Substance
- PAZOPANIB HYDROCHLORIDE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- pazopanib
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PAZOPANIB HYDROCHLORIDE | 200 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 33Y9ANM545 |
| Rxcui | 867502 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 82293-022-10 | pazopanib | 120 in 1 BOTTLE | TABLET, FILM COATED | 120 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 82293-022 | PAZOPANIB (PAZOPANIB HYDROCHLORIDE) TABLET, FILM COATED [NOVUGEN PHARMA (USA) LLC.] | 2 | Current NDC, 1 package rows | 20240820_25305d33-caa0-4577-8b7b-06e430c34c39.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 82293-022-10 | 82293002210 | 120 TABLET, FILM COATED in 1 BOTTLE (82293-022-10) | 2024-04-24 | No | No | Historical |